Myasthenia Gravis (MG) is an autoimmune disease which is characterised by disruption of signal transmission at neuromuscular junction. We aimed to search about a newly reported association between MG and West Nile Virus (WNV) infection.
Methods
We searched WNV IgG by ELISA in serum samples of 50 available MG patients and 38 controls.
Results
None of the samples gave positive results for past WNV infection.
Conclusion
No evidence of past WNV infection was found in our study population of MG patients. This may have been because MG has been showed to be related with neuroinvasive WNV, which none of our study subjects seem to have had based on their stories. New multicentre studies focusing on immunological mechanisms and held with larger groups or especially neuroinvasive disease patients can cast light onto the answer of this question.
SmithburnKCHughesTPBurkeAW. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg1940; 20: 471–492.
2.
KhabbazRAOstroffSMLeducJWEmerging and reemerging infectious disease threats. In: MandellGLBennettJEDolinR (eds) Principles and Practice of Infectious Diseases, Philadelphia, PA: Elsevier Saunder, 2010, pp. 199–220.
3.
Centers for Disease Control and Prevention (CDC). West Nile virus activity United States, 2007. MMWR Morb Mortal Wkly Rep2008; 57: 720–723.
Berrih-AkninSLe PanseR. Myastheniagravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun2014; 52: 90–100.
6.
LeisAAStokicDS. Neuromuscular manifestations of human West Nile Virus infection. Curr Treat Options Neurol2005; 7: 15–22.
7.
LeisAAStokicDS. Neuromuscular manifestations of West Nile Virus infection. Front Neurol2012; 3: 37–37.
8.
LeisAASzatmaryGRossMA. West Nile Virus infection and myasthenia gravis. Muscle Nerve2014; 49: 26–29.
9.
LangedijkJVosWDoornumG. Identification of cross-reactive epitopes recognized by HIV-1 false-positive sera. AIDS1992; 6: 1547–1548.
10.
TurnerRB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol1997; 78: 531–539; quiz 539–540.
11.
LevinsonWJawetzEHumoral immunity. In: LevinsonWJawetzE (eds) Medical Microbiology and Immunology: examination and board review, New York, NY: McGraw-Hill, 2002, pp. 391–392–391–392.
12.
KarlıkayaGYükselGYıldırımB. Intravenous immunglobulin treatment; The effect on different hematological and biochemical parameters. J Neurol Sci [Turk]2007; 24: 104–108.
13.
OchsHDFischerSHLeeML. Intravenous immunoglobulin home treatment for patientswith primary immunodeficiency diseases. Lancet1986; 1: 610–611.
14.
SejvarJJ. The long-term outcomes of human West Nile Virus infection. Clin Infect Dis2007; 15: 1617–1624.
15.
ErgunayKSayganMBAydoganS. West Nile Virus seroprevalence in blood donors from Central Anatolia, Turkey. Vector Borne Zoonotic Dis2010; 10: 771–775.
16.
AyturanSAydoğanSErgünayK. Investigation of West Nile virus seroprevalence in Hacettepe University Hospital blood donors and confirmation of the positive results by plaque reduction neutralization test. Mikrobiyol Bül2011; 45: 113–124.
17.
CarsonPJPrinceHEBiggerstaffBJ. Characteristics of antibody responses in West Nile Virus-seropositive blood donors. J Clin Microbiol2014; 52: 57–60.
18.
OkunoYFukunagaTTadanoM. Serological studies on volunteers inoculated experimentally with a dengue virus strain in 1943. Biken J1983; 26: 161–163.
19.
ImrieAMeeksJGuraryA. Antibody to dengue 1 detected more than 60 years after infection. Viral Immunol2007; 20: 672–675.
20.
PolandJDCalisherCHMonathTP. Persistence of neutralizing antibody 30–35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ1981; 59: 895–900.
21.
PhillipsLH2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci2003; 998: 407–412.
22.
ZivadinovRJurjevicAWillheimK. Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. Neuroepidemiology1998; 17: 265–272.
23.
SarduCCoccoEMereuA. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity. PLoS One2012; 7: e32487–e32487.
